Back to Search
MICHAEL CARDUCCI, MD
MD
Diagnostic Radiology Physician
NPI: 1902830045IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
10479(NV)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 1997
Research & Publications (20)
Fenugreek: a naturally occurring edible spice as an anticancer agent.
PMID 19197146·Cancer Biol Ther·2009
8-other
Pharmacogenetic pathway analysis of docetaxel elimination.
PMID 18509327·Clin Pharmacol Ther·2009
4-observational
Concordance of cancer patients' function, symptoms, and supportive care needs.
PMID 19657724·Qual Life Res·2009
8-other
Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.
PMID 19213669·Clin Genitourin Cancer·2009
8-other
NCCN clinical practice guidelines in oncology: testicular cancer.
PMID 19555582·J Natl Compr Canc Netw·2009
6-review
Topical tacrolimus treatment for localized pretibial bullous phemphigoid.
PMID 18410329·J Eur Acad Dermatol Venereol·2009
5-case
NCCN clinical practice guidelines in oncology: kidney cancer.
PMID 19555584·J Natl Compr Canc Netw·2009
6-review
HIF-1alpha inhibition as a novel mechanism of cardiac glycosides in cancer therapeutics.
PMID 19236270·Expert Opin Investig Drugs·2009
8-other
Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo.
PMID 19372553·Mol Cancer Ther·2009
7-preclinical
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.
PMID 19363497·Nat Med·2009
7-preclinical
The central proline rich region of POB1/REPS2 plays a regulatory role in epidermal growth factor receptor endocytosis by binding to 14-3-3 and SH3 domain-containing proteins.
PMID 18647389·BMC Biochem·2008
8-other
Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer.
PMID 18785254·Cancer·2008
3-trial
A multiple-loop, double-cube microarray design applied to prostate cancer cell lines with variable sensitivity to histone deacetylase inhibitors.
PMID 18980983·Clin Cancer Res·2008
8-other
A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer.
PMID 19047126·Clin Cancer Res·2008
3-trial
Acute pancreatitis as initial manifestation of systemic lupus erythematosus and subacute cutaneous lupus erythematosus: report of two cases.
PMID 18625645·Lupus·2008
5-case
Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer.
PMID 18565882·J Clin Oncol·2008
3-trial
Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay.
PMID 18519775·Clin Cancer Res·2008
3-trial
Phase II open-label study of oral piritrexim in patients with advanced carcinoma of the urothelium who have experienced failure with standard chemotherapy.
PMID 18501080·Clin Genitourin Cancer·2008
3-trial
(S,S)-4''-Cyano-7,7''-dimethoxy-3',6'-dioxodispiro[indane-2,2'-piperazine-5',2''-indane]-4-carboxamide methanol solvate: interrupting the amide-to-amide hydrogen-bonded tape.
PMID 18682650·Acta Crystallogr C·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2020 PALOMINO LN, #100
LAS VEGAS, NV 89106 - Phone
- (702) 759-8600
Quick Facts
- NPI
- 1902830045
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile